Quest, I got the feeling that it maybe a little while longer. Mayne may have another bidder from reports from down under. However feel good that there's an acceleration clause in the U.S. deal -14M. I guess the back up plan for Nipent would be Geneuro to martket it....but CEO was pretty positive that Nipent-EU deal would be completed with Mayne. The Montigen pipeline looks exciting. The benefits that their product- pill form, long shelf life and wide variety of cancers they can go after. Look to see some nice benefits on a partnership early...hinted at now twice by Manuso.